Bio-gene Technology Ltd. · ASX:BGT
Bio-gene Technology — Investor Presentation (May 2023)
19 slides from Bio-gene Technology's investor presentation, May 3, 2023
Slide 1: Bio-Gene Technology Limited Company Update
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED 3 MAY 2023 Company Update PRESENTED BY Richard Jagger CEO Peter May Exec Director, R&D
Slide 2: Disclaimer
DISCLAIMER This presentation has been prepared by Bio-Gene Technology Limited (ASX:BGT) (the Company). This presentation is not, and should not be considered, an offer or invitation to apply for or purchase securities in the Company or as a recommendation or inducement to make an offer or invitation
Slide 3: Business Update Agenda
BUSINESS UPDATE AGENDA • Global challenges & pest control • Bio-Gene’s chemistry & technology platform • Target Market defined • Commercialisation pathway & Business Model • Revenue expectations • Key partnerships in target segments • Synergy studies & the upside • Summary • Next Steps 3
Slide 4: Global Challenges and Resistant Pest Control
GLOBAL CHALLENGES AND RESISTANT PEST CONTROL Food Security & Public Health • Growing Population = more food “Without Crop Protection, crop • Climate Change = more mosquitos losses would double each year” CropLife Financial Impact • Production lost to pests = higher costs, lost income “No new public
Slide 5: Bio-Gene's Chemistry Is a Step-Change for Resistant Pest Control
BIO-GENE'S CHEMISTRY IS A STEP-CHANGE FOR RESISTANT PEST CONTROL • Novel Mode of Action (MoA) • Last new MoA commercialised in 2008, with current sales of US$2.3bn • Naturally derived and safe chemistry • Efficacy across a number of target pests QcideTM FlavocideTM Natural Compound Nature Identical
Slide 6: Target Markets
TARGET MARKETS 52% Crop Protection Food, Fibre & Includes Grain storage Grain Storage segment, valued at ~ US$1 billion US$31.1bn Addressable Market 13% 16% Consumer Applications 19% Sprays, Creams, Lotions Public Health & Personal Vector Control for Repellents Malaria, Zika & Dengue Animal Health L
Slide 7: Commercialisation Pathway and Business Model
COMMERCIALISATION PATHWAY AND BUSINESS MODEL Commercialisation pathway • Active ingredient registrations • Product development, Marketing & distribution with strong commercial partners • Developing proprietary manufacturing and production know-how Revenue drivers 1. Technology licensing fees 2. Mile
Slide 8: Revenue Expectations
REVENUE EXPECTATIONS Revenue profile ($m) FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029 FY 2030 FY 2031 Licence fees Milestone Active Ingredients Royalty Bio-Gene expects highly profitable revenue streams from FY 2026 onwards 8
Slide 9: Target Market: Public Health – Clarke Commercial Development Agreement
TARGET MARKET: PUBLIC HEALTH CLARKE COMMERCIAL DEVELOPMENT AGREEMENT Clarke is the largest vertically integrated company in public health mosquito control Extended Commercial Validation of work to date Next Steps Agreement Excellent collaboration between Targeted formulation development Now includes
Slide 10: Target Market: Consumer Products – Evergreen Commercial Development Agreement
TARGET MARKET: CONSUMER PRODUCTS EVERGREEN COMMERCIAL DEVELOPMENT AGREEMENT Evergreen is a market leader in consumer products across Europe and in Australia/New Zealand Initial Field of Use Other market opportunities Next Steps Flying insect control Actively exploring additional Continue development
Slide 11: Target Market: Crop Protection – Binding Terms Agreed with STK Bio-Ag
TARGET MARKET: CROP PROTECTION BINDING TERMS AGREED WITH STK BIO-AG STK applies advanced botanical science and bio-ag technology in the development & commercialisation of natural crop protection solutions for growers worldwide Licencing arrangements Registering Active Ingredient Alliance, partnershi
Slide 12: Explaining Synergy - The Holy Grail
EXPLAINING SYNERGY - THE HOLY GRAIL What is Synergy? • Synergy occurs when the effect of two or more agents (or compounds) in combination is greater than the additive effect of those same agents Why does Synergy occur? • Synergy is unpredictable and uncommon, but it can occur when different Modes of
Slide 13: Studies Confirm Synergy
STUDIES CONFIRM SYNERGY Synergy confirmed with Qcide/Pyrethrin combination1 • Novel Mode of Action allows for this synergistic effect • Cost effective at lower rates 1In spray/topical applications, Qcide with pyrethrins against houseflies (M. domestica). Statistically valid results confirmed synergy
Slide 14: Commercial Opportunities via Synergy
COMMERCIAL OPPORTUNITIES VIA SYNERGY • Significantly expands commercial opportunities in global insecticide market: • Lower dosage requirements, reduced cost and improved environmental safety • Addresses resistance issues • Extends the value of commercial partner post-patent products with added bene
Slide 15: Manufacturing Developments
MANUFACTURING DEVELOPMENTS • As reported in December 2022 significant progress have been across: • Production know-how & trade secrets • Scalability of product • Cost management • Process improvements • Manufacturing partner engagement • Data development for registration dossiers 15
Slide 16: Summary
SUMMARY • There is a real need for new Mode of Action insecticides globally • Our chemistry has been validated by commercial parties • Key initial partnerships have been established with many more planned • Business model is developed • Synergy study results expand commercial opportunities • We will
Slide 17: Next Steps
NEXT STEPS • Finalise STK agreement • Additional Synergy testing • Advance other commercial partnerships • Deliver manufacturing partnerships • Further strengthen our IP platform • Advance our regulatory applications with governing bodies • Continue to advance our business model via licences, milest
Slide 18: Bio-Gene Technology Limited Q&A
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED Q&A richardj@bio-gene.com.au peterm@bio-gene.com.au rodv@bio-gene.com.au www.bio-gene.com.au
Slide 19: Sources
SOURCES Slide Sources 6 US EPA 2017, WHO 2017, Zoetis & Provue Market Research, Markets & Markets 9 Global Mosquito Control Market, Research Report 2020, Forecast to 2026 10 Research and Markets report, December 2019: Europe Household Insecticides Market to 2027 - Regional Analysis and Forecasts By
Bio-gene Technology — Investor Presentation (May 2023) on 6ix